Press releases Glycovax Pharma develops a vaccine against COVID-19 – A semi-synthetic vaccine in the preclinical phase04.21.2020Download the press release here Glycovax Pharma Files a Patent Application for a New Semi-Synthetic Vaccine against Breast Cancers04.04.2018Download the press release here